Evidence map›Paper›PMID 33879616›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension.

Zdravka Daneva, Corina Marziano, Matteo Ottolini, Yen-Lin Chen, Thomas M Baker, Maniselvan Kuppusamy, Aimee Zhang, Huy Q Ta, Claire E Reagan, Andrew D Mihalek and 8 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Role of Caveolae and Caveolin in Vascular Physiology and Pathology.Journal of the American Heart Association · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Nitrosation of CD36 Regulates Endothelial Function and Serum Lipids.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  15. Small molecule probes for peroxynitrite detection.Redox biochemistry and chemistry · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Single-Cell RNA-Seq Reveals Coronary Heterogeneity and Identifies CD133Arteriosclerosis, thrombosis, and vascular biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Zdravka DanevaRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.
Corina MarzianoRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.ORCID 0000-0002-1785-7970
Matteo OttoliniRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.
Yen-Lin ChenRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.
Thomas M BakerRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.
Maniselvan KuppusamyRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.ORCID 0000-0003-4579-584X
Aimee ZhangDepartment of Surgery, University of Virginia, Charlottesville, VA 22908.ORCID 0000-0002-3660-3917
Huy Q TaDepartment of Surgery, University of Virginia, Charlottesville, VA 22908.
Claire E ReaganDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908.ORCID 0000-0001-9955-4916
Andrew D MihalekDepartment of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA 22908.
Ramesh B KasettiDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107.ORCID 0000-0001-7874-3988
Yuanjun ShenPittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213.ORCID 0000-0002-8183-9531
Brant E IsaksonRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908.ORCID 0000-0002-7692-6294
Richard D MinshallDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL 60612.ORCID 0000-0003-3164-475X
Gulab S ZodeDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107.ORCID 0000-0002-7823-2595
Elena A GoncharovaPittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213.
Victor E LaubachDepartment of Surgery, University of Virginia, Charlottesville, VA 22908.ORCID 0000-0001-9673-5383
Swapnil K SonkusareRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908; swapnil.sonkusare@virginia.edu.ORCID 0000-0001-9587-9342
University of Virginia · USUniversity of North Texas · USUniversity of Pittsburgh · USUniversity of Illinois Chicago · US

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A. · 2014 to 2023
$24.0M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Paracrine TNF signaling impairs endothelial TRPV4 microdomains in obesityR01HL142808 · NHLBI · UNIVERSITY OF VIRGINIA · PI Swapnil K. Sonkusare · 2019 to 2026
$4.4M
Flow-Activated Calcium Signaling Microdomains in Small Pulmonary ArteriesR01HL146914 · NHLBI · UNIVERSITY OF VIRGINIA · PI Swapnil K. Sonkusare · 2019 to 2026
$3.8M
New Signaling Networks in Vascular Smooth MuscleR01HL147555 · NHLBI · UNIVERSITY OF VIRGINIA · PI DEREWENDA, ZYGMUNT S, SOMLYO, AVRIL V. · 2020 to 2024
$3.6M
HIPPO Signaling in Pulmonary Arterial HypertensionR01HL130261 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GONCHAROVA, ELENA · 2016 to 2023
$3.5M
TSC2 Signaling in Pulmonary Arterial HypertensionR01HL113178 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GONCHAROVA, ELENA · 2012 to 2021
$3.1M
GATA-6 in pulmonary arterial hypertensionR01HL150638 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GONCHAROVA, ELENA, TROJANOWSKA, MARIA · 2020 to 2023
$2.6M
Fibroblast Mediated Mechanisms of Pulmonary HypertensionR01HL142636 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MINSHALL, RICHARD D · 2019 to 2023
$2.0M
NHLBI NIH HHS P01 HL120840NHLBI NIH HHS R01 HL113178NHLBI NIH HHS R01 HL130261NHLBI NIH HHS R01 HL142636NHLBI NIH HHS R01 HL142808NHLBI NIH HHS R01 HL146914NHLBI NIH HHS R01 HL147555NHLBI NIH HHS R01 HL150638NIAID NIH HHS T32 AI007163
6 · The paper itself

Abstract

Recent studies have focused on the contribution of capillary endothelial TRPV4 channels to pulmonary pathologies, including lung edema and lung injury. However, in pulmonary hypertension (PH), small pulmonary arteries are the focus of the pathology, and endothelial TRPV4 channels in this crucial anatomy remain unexplored in PH. Here, we provide evidence that TRPV4 channels in endothelial cell caveolae maintain a low pulmonary arterial pressure under normal conditions. Moreover, the activity of caveolar TRPV4 channels is impaired in pulmonary arteries from mouse models of PH and PH patients. In PH, up-regulation of iNOS and NOX1 enzymes at endothelial cell caveolae results in the formation of the oxidant molecule peroxynitrite. Peroxynitrite, in turn, targets the structural protein caveolin-1 to reduce the activity of TRPV4 channels. These results suggest that endothelial caveolin-1-TRPV4 channel signaling lowers pulmonary arterial pressure, and impairment of endothelial caveolin-1-TRPV4 channel signaling contributes to elevated pulmonary arterial pressure in PH. Thus, inhibiting NOX1 or iNOS activity, or lowering endothelial peroxynitrite levels, may represent strategies for restoring vasodilation and pulmonary arterial pressure in PH.

Indexed as

AnimalsArterial PressureCaveolaeEndothelium, VascularHumansMiceMice, KnockoutNADPH Oxidase 1Nitric Oxide Synthase Type IIPeroxynitrous AcidProtein Kinase CPulmonary Arterial HypertensionTRPV Cation ChannelsNADPH Oxidase 1Nitric Oxide Synthase Type IINos2 protein, mouseNOX1 protein, mousePeroxynitrous AcidProtein Kinase CTrpv4 protein, mouseTRPV Cation Channelscaveolinendotheliumperoxynitritepulmonary hypertensionTRP channel

Identifiers

PMID33879616
PMCPMC8092599
OpenAlexW3154340860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.